Pricing Log in Create free account

BioVie Inc. (BIVI) vs SeaStar Medical Holding Corporation (ICU)

BioVie Inc. and SeaStar Medical Holding Corporation are both Biotechnology companies. BioVie Inc. and SeaStar Medical Holding Corporation are of similar size ($10.3M and $10.2M). BioVie Inc. has the higher net margin (0.00% vs −795.5%) and the lower return on invested capital (−1,095.0% vs 0.00%). Across the 13 metrics below, BioVie Inc. leads on 8 and SeaStar Medical Holding Corporation on 5.

Valuation

Metric BIVI ICU Biotechnology median
P/E n/m n/m 10.60
P/S n/m 4.55 9.40
P/B 0.95 1.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.99 9.02
Earnings yield (235.07%) (204.71%) (32.88%)
Free cash flow yield (195.94%) (175.54%) (23.13%)

Profitability

Metric BIVI ICU Biotechnology median
Gross margin 0.00% 92.64% 68.51%
Operating margin 0.00% (816.75%) 0.00%
Net margin 0.00% (795.50%) 0.00%
Free cash flow margin 0.00% (799.36%) 0.00%
Return on equity (151.06%) (356.87%) (51.96%)
Return on assets (123.51%) (160.02%) (46.06%)
Return on invested capital (1,095.01%) 0.00% 0.00%

Growth

Metric BIVI ICU Biotechnology median
Revenue growth (TTM) — 123.63% 6.76%
EPS growth (last fiscal year) 74.83% 91.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIVI ICU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.59 1.89 4.97
Net debt to EBITDA 0.40 0.99 1.01

Dividend

Metric BIVI ICU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BIVI ICU Biotechnology median
Market cap 10.32m 10.20m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack